Chief Business Officer · Viridian Therapeutics, Inc. (VRDN)

Adam Levy

A named executive officer of Viridian Therapeutics in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$868,618

Salary $345,000Stock awards $0Bonus $82,800

FY2017: $1,112,149

3rd of 4 named executive officers at Viridian Therapeutics by FY2018 total.

4 named officers on file for Viridian Therapeutics, FY2018

Adam Levy’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • VRDN’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Viridian Therapeutics’s whole pay program stands against its peers

  • Viridian Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VRDN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 3, 2019 (DEF 14A).

Free

Get Adam Levy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Adam Levy compensation by year

Viridian Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Viridian Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$300,000$345,000
Bonus$108,000$82,800
Stock awards$0$0
Option awards$704,149$440,818
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$1,112,149$868,618

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viridian Therapeutics, Inc. DEF 14A filed May 3, 2019, accession 0001590750-19-000021, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Viridian Therapeutics, Inc. filed document, accession 0001590750-19-000021. Every figure is read from that document and cited to the page and table it appears in. Filed May 3, 2019.

$1.1M
$869K
FY17
FY18
SalaryBonusOption awards

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option57,494—$1.05
Option47,396—$11.01
Option61,667—$7.50

Per the Outstanding Equity Awards at Fiscal Year-End table in Viridian Therapeutics, Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Viridian Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
William MarshallChief Executive Officer and President$1,987,005
Paul RubinExecutive Vice President, Research and Development$976,769
Adam Levy · this pageChief Business Officer$868,618
Jason LeveroneChief Financial Officer$824,667

The full Viridian Therapeutics compensation record

free company brief

This page is one person within Viridian Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Viridian Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Viridian Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Adam Levy's compensation dossier · One-time report. No refunds.